Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, Sept. 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0617109/Prosthetic-Heart-Valves---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices
Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global prosthetic heart valves market. The report provides market landscape, competitive landscape and market trends information on the prosthetic heart valves market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the prosthetic heart valves market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Edwards Lifesciences Corporation, St. Jude Medical and Sorin Group.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the prosthetic heart valves market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the prosthetic heart valves market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global prosthetic heart valves market and the factors shaping it.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 GlobalData Report Guidance 9
3 Disease Overview: Valvular Heart Disease 10
3.1 Types of Valvular Heart Disease 10
3.2 Symptoms and Diagnosis of Valvular Heart Disease 10
3.3 Treatment of Valvular Heart Disease 10
3.4 Epidemiology 11
4 Device Overview: Prosthetic Heart Valves 12
4.1 Prosthetic Heart Valve-Based Treatment of Valvular Heart Disease 12
4.2 Prosthetic Heart Valves: Market Segmentation 12
4.2.1 Mechanical Heart Valves 13
4.2.2 Tissue Heart Valves 13
4.2.3 Transcatheter Heart Valves 13
5 Prosthetic Heart Valves: Global Market Characterization 14
5.1 Prosthetic Heart Valves Market, Global, Revenue ($m), Historic, 2003?2010 14
5.2 Prosthetic Heart Valves Market, Global, Revenue ($m), Forecast, 2010?2017 15
5.3 Prosthetic Heart Valves, Key Trends 16
5.3.1 Launch and Faster Adoption of Transcatheter Heart Valves 16
5.3.2 Increasing Shift from Mechanical Heart Valves to Tissue Heart Valves 16
5.4 Opportunities and Unmet Needs 17
5.4.1 Opportunity: Substantial Under-treated Population Provides Significant Market Potential to Companies 17
5.4.2 Unmet Need: Risks Associated with Implantation to Restrain Growth of the Market for Prosthetic Heart Valves 17
5.5 Prosthetic Heart Valves, Market Dynamics 17
5.5.1 Market Drivers 17
5.5.2 Market Restraints 21
6 Prosthetic Heart Valves Market: Segment Analysis 23
6.1 Transcatheter Heart Valves Market, Revenue ($m), Historic, 2003 – 2010 23
6.2 Transcatheter Heart Valves Market, Revenue ($m), Forecast, 2010 – 2017 24
6.3 Transcatheter Heart Valves, Market Dynamics 25
6.3.1 Market Drivers 25
6.3.2 Market Restraint 25
6.4 Tissue Heart Valves Market, Revenue ($m), Historic, 2003 – 2010 26
6.5 Tissue Heart Valves Market, Revenue ($m), Forecast, 2010 – 2017 27
6.6 Tissue Heart Valves, Market Dynamics 28
6.6.1 Market Driver 28
6.6.2 Market Restraint 28
6.7 Mechanical Heart Valves Market, Revenue ($m), Historic, 2003 – 2010 29
6.8 Mechanical Heart Valves Market, Revenue ($m), Forecast, 2010 – 2017 30
6.9 Mechanical Heart Valves, Market Dynamics 31
6.9.1 Market Driver 31
6.9.2 Market Restraint 31
7 Prosthetic Heart Valves Market, by Country, Revenue ($m), 2003 – 2017 32
7.1 Prosthetic Heart Valves Market, the US, Revenue ($m), By Segment, Historic, 2003 – 2010 32
7.2 Prosthetic Heart Valves Market, the US, Revenue ($m), By Segment, Forecast, 2010 – 2017 33
7.3 Prosthetic Heart Valves Market, Canada, Revenue ($m), By Segment, Historic, 2003 – 2010 34
7.4 Prosthetic Heart Valves Market, Canada, Revenue ($m), By Segment, Forecast, 2010 – 2017 35
7.5 Prosthetic Heart Valves Market, the UK, Revenue ($m), By Segment, Historic, 2003 – 2010 36
7.6 Prosthetic Heart Valves Market, the UK, Revenue ($m), By Segment, Forecast, 2010 – 2017 37
7.7 Prosthetic Heart Valves Market, Germany, Revenue ($m), By Segment, Historic, 2003 – 2010 38
7.8 Prosthetic Heart Valves Market, Germany, Revenue ($m), By Segment, Forecast, 2010 – 2017 39
7.9 Prosthetic Heart Valves Market, France, Revenue ($m), By Segment, Historic, 2003 – 2010 40
7.10 Prosthetic Heart Valves Market, France, Revenue ($m), By Segment, Forecast, 2010 – 2017 41
7.11 Prosthetic Heart Valves Market, Italy, Revenue ($m), By Segment, Historic, 2003 – 2010 42
7.12 Prosthetic Heart Valves Market, Italy, Revenue ($m), By Segment, Forecast, 2010 – 2017 43
7.13 Prosthetic Heart Valves Market, Spain, Revenue ($m), By Segment, Historic, 2003 – 2010 44
7.14 Prosthetic Heart Valves Market, Spain, Revenue ($m), By Segment, Forecast, 2010 – 2017 45
7.15 Prosthetic Heart Valves Market, Japan, Revenue ($m), By Segment, Historic, 2003–2010 46
7.16 Prosthetic Heart Valves Market, Japan, Revenue ($m), By Segment, Forecast, 2010 – 2017 47
7.17 Prosthetic Heart Valves Market, China, Revenue ($m), By Segment, Historic, 2003 – 2010 48
7.18 Prosthetic Heart Valves Market, China, Revenue ($m), By Segment, Forecast, 2010 – 2017 49
7.19 Prosthetic Heart Valves Market, India, Revenue ($m), By Segment, Historic, 2003 – 2010 50
7.20 Prosthetic Heart Valves Market, India, Revenue ($m), By Segment, Forecast, 2010 – 2017 51
7.21 Prosthetic Heart Valves Market, Australia, Revenue ($m), By Segment, Historic, 2003 – 2010 52
7.22 Prosthetic Heart Valves Market, Australia, Revenue ($m), By Segment, Forecast, 2010 – 2017 53
7.23 Prosthetic Heart Valves Market, Brazil, Revenue ($m), By Segment, Historic, 2003 – 2010 54
7.24 Prosthetic Heart Valves Market, Brazil, Revenue ($m), By Segment, Forecast, 2010 – 2017 55
8 Prosthetic Heart Valves Market: Competitive Landscape 56
8.1 Prosthetic Heart Valves Market, Key Company Share (%), 2010 56
8.2 Prosthetic Heart Valves Market, Key Market Participants 57
8.2.1 Edwards Lifesciences Corporation 57
8.2.2 Medtronic, Inc. 62
8.2.3 St. Jude Medical, Inc. 66
8.2.4 Sorin Group 69
9 Prosthetic Heart Valves Market: Key Marketed Products 73
9.1 SAPIEN XT Transcatheter Heart Valve (Edwards Lifesciences Corporation) 73
9.1.1 Product Description 73
9.2 Features and Benefits 73
9.3 Carpentier-Edwards PERIMOUNT Magna Mitral Ease Heart Valve (Edwards Lifesciences Corporation) 73
9.3.1 Product Description 73
9.3.2 Features and Benefits 73
9.4 3f Aortic Bioprosthesis (Medtronic, Inc.) 74
9.4.1 Product Description 74
9.4.2 Features and Benefits 74
9.5 Trifecta Valve (St. Jude Medical) 74
9.5.1 Product Description 74
9.5.2 Features and Benefits 74
9.6 CarboMedics Standard Aortic Valve (Sorin Group) 75
9.6.1 Product Description 75
9.6.2 Features and Benefits 75
9.7 Perceval S (Sorin Group) 75
9.7.1 Product Description 75
9.7.2 Features and Benefits 75
10 Prosthetic Heart Valves Market: Strategic Pipeline Assessment 76
10.1 Pipeline Products Assessment for Prosthetic Heart Valves by Development Stage, Global, 2010 76
10.2 Transcatheter Heart Valves, Pipeline Analysis 77
10.2.1 18 Fr Percutaneous Aortic Valve System 78
10.2.2 22 Fr Percutaneous Aortic Valve System 79
10.2.3 Acurate TA Aortic Valve Replacement System 80
10.2.4 CoreValve ReValving System 81
10.2.5 Edwards SAPIEN Transcatheter Heart Valve 87
10.2.6 Edwards SAPIEN XT Valve - NovaFlex Delivery System 89
10.2.7 Elast-Eon Polymer Heart Valve 90
10.2.8 JenaValve Transapical TAVI System 90
10.2.9 Lotus Valve System 92
10.2.10 Transapical AVR System 93
10.3 Tissue Heart Valves, Pipeline Analysis 95
10.3.1 ATS 3F Enable Sutureless Valve 96
10.3.2 Carpentier-Edwards PERIMOUNT Magna Ease Aortic Heart Valve 97
10.3.3 dCELL Heart Valve 99
10.3.4 Freedom Solo 99
10.3.5 Mitroflow Aortic Pericardial Heart Valve 101
10.3.6 Perceval S Aortic Heart Valve 103
10.3.7 Synergraft Xenograft Heart Valve 105
10.3.8 Ventor Embracer 106
10.4 Mechanical Heart Valves, Pipeline Analysis 107
10.4.1 ATS Open Pivot Heart Valve-ForceField 107
11 Prosthetic Heart Valves Market: Deals Landscape 108
11.1 Key Acquisition Deals 108
11.1.1 Medtronic Completes Acquisition of ATS Medical 108
11.1.2 Medtronic Acquires CoreValve from Sofinnova Partners, Apax Partners, HealthCap and Maverick Capital 109
11.1.3 ATS Medical Acquires 3F Therapeutics 110
11.1.4 Vascutek Acquires Bioprosthetic Heart Valve Business of Kohler Chemie 110
11.2 Key Partnership Deals 111
11.2.1 On-X Life Technologies Enters into Licensing Agreement with Cleveland Clinic 111
11.2.2 Sorin Signs Distribution Agreement with Japan Lifeline 112
11.2.3 Medtronic Enters Into Licensing Agreement with Arbor Surgical Technologies 112
11.3 Key Venture Financing Deals 113
11.3.1 CardiAQ Valve Technologies Secures $6.5m in Series A Financing Round 114
11.3.2 Direct Flow Medical Secures $40m in Third Round of Financing 114
11.3.3 Symetis Secures $21.2m in Venture Financing 114
12 Appendix 115
12.1 Market Definitions 115
12.1.1 Prosthetic Heart Valves 115
12.2 Abbreviations 116
12.3 Sources 117
12.4 Research Methodology 117
12.4.1 Secondary Research 117
12.4.2 Primary Research 118
12.4.3 Models 118
12.4.4 Forecasts 118
12.4.5 Expert Panel 119
12.5 GlobalData Consulting 119
12.6 Contact Us 119
12.7 Disclaimer 119
List of Tables
Table 1: Prosthetic Heart Valves Market, Global, Revenue ($m), 2003–2010 14
Table 2: Prosthetic Heart Valves Market, Global, Revenue ($m), 2010–2017 15
Table 3: Population Aged 65 and Above (million), Global, 2004-2010 18
Table 4: Prevalence of Aortic Stenosis, the US, 2004 19
Table 5: Tissue Heart Valves Replacement, Global, Procedures, 2010–2016 20
Table 6: Cardiac Valve Procedures, Inpatient Hospital Reimbursements based on MS-DRGs, US 21
Table 7: Transcatheter Heart Valves Market, Global, Revenue ($m), 2003–2010 23
Table 8: Transcatheter Heart Valves Market, Global, Revenue ($m), 2010–2017 24
Table 9: Tissue Heart Valves Market, Global, Revenue ($m), 2003–2010 26
Table 10: Tissue Heart Valves Market, Global, Revenue ($m), 2010–2017 27
Table 11: Mechanical Heart Valves Market, Global, Revenue ($m), 2003–2010 29
Table 12: Mechanical Heart Valves Market, Global, Revenue ($m), 2010–2017 30
Table 13: Prosthetic Heart Valves Market, the US, Revenue ($m), 2003–2010 32
Table 14: Prosthetic Heart Valves Market, the US, Revenue ($m), 2010–2017 33
Table 15: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2003–2010 34
Table 16: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2010–2017 35
Table 17: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2003–2010 36
Table 18: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2010–2017 37
Table 19: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2003–2010 38
Table 20: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2010–2017 39
Table 21: Prosthetic Heart Valves Market, France, Revenue ($m), 2003–2010 40
Table 22: Prosthetic Heart Valves Market, France, Revenue ($m), 2010–2017 41
Table 23: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2003–2010 42
Table 24: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2010–2017 43
Table 25: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2003–2010 44
Table 26: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2010–2017 45
Table 27: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2003–2010 46
Table 28: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2010–2017 47
Table 29: Prosthetic Heart Valves Market, China, Revenue ($m), 2003–2010 48
Table 30: Prosthetic Heart Valves Market, China, Revenue ($m), 2010–2017 49
Table 31: Prosthetic Heart Valves Market, India, Revenue ($m), 2003–2010 50
Table 32: Prosthetic Heart Valves Market, India, Revenue ($m), 2010–2017 51
Table 33: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2003–2010 52
Table 34: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2010–2017 53
Table 35: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2003–2010 54
Table 36: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2010–2017 55
Table 37: Prosthetic Heart Valves Market, Key Company Shares ($m), 2010 56
Table 38: Edwards Lifesciences Corporation, Prosthetic Heart Valves, Marketed Products 58
Table 39: Edwards Lifesciences Corporation, Prosthetic Heart Valves, Pipeline Products 58
Table 40: Medtronic Inc., Prosthetic Heart Valves, Marketed Products 62
Table 41: Medtronic Inc., Prosthetic Heart Valves, Pipeline Products 63
Table 42: St. Jude Medical Inc., Prosthetic Heart Valves, Marketed Products 67
Table 43: St. Jude Medical Inc., Prosthetic Heart Valves, Pipeline Products 67
Table 44: Sorin S.p.A., Prosthetic Heart Valves, Marketed Products 70
Table 45: Sorin S.p.A., Prosthetic Heart Valves, Pipeline Products 70
Table 46: SAPIEN XT Transcatheter Heart Valve, Features and Benefits 73
Table 47: Carpentier-Edwards PERIMOUNT Magna Mitral Ease, Features and Benefits 73
Table 48: 3f Aortic Bioprosthesis, Features and Benefits 74
Table 49: Trifecta Valve, Features and Benefits 74
Table 50: CarboMedics Standard Aortic Valve, Features and Benefits 75
Table 51: Perceval S, Features and Benefits 75
Table 52: Transcatheter Heart Valves Market, Pipeline Products 77
Table 53: 18 Fr Percutaneous Aortic Valve System- Clinical Trial 78
Table 54: 22 Fr Percutaneous Aortic Valve System- Clinical Trial 79
Table 55: Acurate TA Aortic Valve Replacement System- Clinical Trial 80
Table 56: CoreValve ReValving System- Clinical Trial I 81
Table 57: CoreValve ReValving System- Clinical Trial II 82
Table 58: CoreValve ReValving System- Clinical Trial III 83
Table 59: CoreValve ReValving System- Clinical Trial IV 84
Table 60: CoreValve ReValving System- Clinical Trial V 85
Table 61: CoreValve ReValving System- Clinical Trial VI 86
Table 62: Edwards SAPIEN Transcatheter Heart Valve- Clinical Trial I 87
Table 63: Edwards SAPIEN Transcatheter Heart Valve- Clinical Trial II 88
Table 64: Edwards SAPIEN XT Valve - NovaFlex Delivery System- Clinical Trial I 89
Table 65: Edwards SAPIEN XT Valve - NovaFlex Delivery System- Clinical Trial II 90
Table 66: JenaValve Transapical TAVI System Clinical Trial I 91
Table 67: JenaValve Transapical TAVI System Clinical Trial II 92
Table 68: Lotus Valve System Clinical Trial 93
Table 69: Transapical AVR System Clinical Trial 94
Table 70: Tissue Heart Valves Market, Pipeline Products 95
Table 71: ATS 3F Enable Sutureless Valve- Clinical Trial I 96
Table 72: ATS 3F Enable Sutureless Valve- Clinical Trial II 97
Table 73: Carpentier-Edwards PERIMOUNT Magna Ease Aortic Heart Valve- Clinical Trial 98
Table 74: Freedom Solo Clinical Trial I 99
Table 75: Freedom Solo Clinical Trial II 100
Table 76: Freedom Solo Clinical Trial III 101
Table 77: Mitroflow Aortic Pericardial Heart Valve Clinical Trial I 102
Table 78: Mitroflow Aortic Pericardial Heart Valve Clinical Trial II 103
Table 79: Perceval S Aortic Heart Valve Clinical Trial I 104
Table 80: Perceval S Aortic Heart Valve Clinical Trial II 105
Table 81: Ventor Embracer Clinical Trial 106
Table 82: Mechanical Heart Valves Market, Pipeline Products 107
Table 83: Prosthetic Heart Valves Market, Acquisition Deals, 2005 – 2010 108
Table 84: Prosthetic Heart Valves Market, Partnership Deals, 2005 – 2010 111
Table 85: Prosthetic Heart Valves Market, Venture Financing Deals, 2005 – 2010 113
List of Figures
Figure 1: Prosthetic Heart Valves, Market Segmentation 12
Figure 2: Prosthetic Heart Valves Market, Global, Revenue ($m), 2003–2010 14
Figure 3: Prosthetic Heart Valves Market, Global, Revenue ($m), 2010–2017 15
Figure 4: Population Aged 65 and Above (million), Global, 2004-2010 18
Figure 5: Prevalence of Aortic Stenosis, the US, 2004 19
Figure 6: Tissue Heart Valves Market, Global, Procedures, 2010–2016 20
Figure 7: Transcatheter Heart Valves Market, Global, Revenue ($m), 2003–2010 23
Figure 8: Transcatheter Heart Valves Market, Global, Revenue ($m), 2010–2017 24
Figure 9: Tissue Heart Valves Market, Global, Revenue ($m), 2003–2010 26
Figure 10: Tissue Heart Valves Market, Global, Revenue ($m), 2010–2017 27
Figure 11: Mechanical Heart Valves Market, Global, Revenue ($m), 2003–2010 29
Figure 12: Mechanical Heart Valves Market, Global, Revenue ($m), 2010–2017 30
Figure 13: Prosthetic Heart Valves Market, the US, Revenue ($m), 2003–2010 32
Figure 14: Prosthetic Heart Valves Market, the US, Revenue ($m), 2010–2017 33
Figure 15: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2003–2010 34
Figure 16: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2010–2017 35
Figure 17: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2003–2010 36
Figure 18: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2010–2017 37
Figure 19: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2003–2010 38
Figure 20: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2010–2017 39
Figure 21: Prosthetic Heart Valves Market, France, Revenue ($m), 2003–2010 40
Figure 22: Prosthetic Heart Valves Market, France, Revenue ($m), 2010–2017 41
Figure 23: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2003–2010 42
Figure 24: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2010–2017 43
Figure 25: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2003–2010 44
Figure 26: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2010–2017 45
Figure 27: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2003–2010 46
Figure 28: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2010–2017 47
Figure 29: Prosthetic Heart Valves Market, China, Revenue ($m), 2003–2010 48
Figure 30: Prosthetic Heart Valves Market, China, Revenue ($m), 2010–2017 49
Figure 31: Prosthetic Heart Valves Market, India, Revenue ($m), 2003–2010 50
Figure 32: Prosthetic Heart Valves Market, India, Revenue ($m), 2010–2017 51
Figure 33: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2003–2010 52
Figure 34: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2010–2017 53
Figure 35: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2003–2010 54
Figure 36: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2010–2017 55
Figure 37: Prosthetic Heart Valves Market, Key Company Shares (%), 2010 56
Figure 38: Prosthetic Heart Valves Market, Edwards Lifesciences Corporation, SWOT Analysis 59
Figure 39: Prosthetic Heart Valves Market, Medtronic Inc., SWOT Analysis 63
Figure 40: Prosthetic Heart Valves Market, St. Jude Medical Inc., SWOT Analysis 67
Figure 41: Prosthetic Heart Valves Market, Sorin S.p.A., SWOT Analysis 71
Figure 42: Prosthetic Heart Valves Market, Pipeline Products, By Development Stage 76
Companies Mentioned
Edwards Lifesciences Corporation
Medtronic, Inc.
St. Jude Medical, Inc.
Sorin Group
To order this report:
Cardiovascular Devices Industry: Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Cardiovascular Devices Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article